CCI Photonics, a spin-out startup from Lancaster University, was established in June 2023. Our innovation in medical technology is driven by a dedicated team and strategic partnerships.

CCI Photonics operates at Research and Enterprise Services, Lancaster University, Bailrigg, Lancaster, LA1 4YT.

We specialise in the making medical instruments and supplies, as well as conducting biotechnology research and development.

 Our Partners

Currently, the process of identifying infectious diseases is limited to the use of different culture media, disposable materials, as well as at least two microbiological techniques involving at least two or more processing machines. All this current steps are time consuming causing between 24 to 48 hour delay to clinical staff. This delay in time is crucial to detect infectious microoganisms that are drug resistant. This strategy is becoming increasingly compromised by the rise in antimicrobial resistance which means that a patient could run the risk of being treated with an ineffective antibiotic for up to 36 hours until the current laboratory methods with consequent increases in morbidity, mortality and the risk of spread of resistant micro-organisms to other patients.